Tenet Reports Results for the Second Quarter Ended June 30, 2020 and Provides Update on Effects of COVID-19
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Tenet Healthcare (THC) Tops Q2 EPS by $1.97
August 3, 2020 4:19 PM EDTTenet Healthcare (NYSE: THC) reported Q2 EPS of $1.26, $1.97 better than the analyst estimate of ($0.71). Revenue for the quarter came in at $3.65 billion versus the consensus estimate of $3.76 billion.
Net income from continuing operations available to common shareholders of $88 million, or $0.83 per diluted share, in 2Q20 versus net income from continuing operations of $24 million, or $0.23 per diluted share, in 2Q19Consolidated Adjusted EBITDA of $732 million in 2Q20 versus $669 million in 2Q19Federal stimulus support received was critical in addressing pandemic challenges, allowing uninterrupted response across our care facilitiesExperienced pronounced volatility in... More


